PM54-A-003-25 - A Multcenter Open-label Phase 1/2 Safety Run In and Expansion Study of PM54 in Combination with Immunotherapy (PM54-A-003-25)
Principal Investigator
Prof Mark Middleton
Contact us
Email: orh-tr.earlyphasenurses@nhs.net
IRAS number
1013898